Page last updated: 2024-08-23

oltipraz and Cardiac Remodeling, Ventricular

oltipraz has been researched along with Cardiac Remodeling, Ventricular in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Guo, M; Hao, MH; Ma, XY; Sun, WP; Tang, Y; Zhu, HY	1

Other Studies

1 other study(ies) available for oltipraz and Cardiac Remodeling, Ventricular

Article	Year
Oltipraz attenuates the progression of heart failure in rats through inhibiting oxidative stress and inflammatory response. European review for medical and pharmacological sciences, 2018, Volume: 22, Issue:24 Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Biomarkers; Cytokines; Disease Models, Animal; Fibrosis; Heart Failure; Inflammation Mediators; Isoproterenol; Myocytes, Cardiac; Oxidative Stress; Pyrazines; Rats, Sprague-Dawley; Recovery of Function; Thiones; Thiophenes; Ventricular Function, Left; Ventricular Remodeling	2018

Article

Year

Oltipraz attenuates the progression of heart failure in rats through inhibiting oxidative stress and inflammatory response.

European review for medical and pharmacological sciences, 2018, Volume: 22, Issue:24

Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Biomarkers; Cytokines; Disease Models, Animal; Fibrosis; Heart Failure; Inflammation Mediators; Isoproterenol; Myocytes, Cardiac; Oxidative Stress; Pyrazines; Rats, Sprague-Dawley; Recovery of Function; Thiones; Thiophenes; Ventricular Function, Left; Ventricular Remodeling

2018